Characterization of bothrojaracin interaction with human prothrombin

Protein Science

Volumn 10, Issue 9, 2001, Pages 1897-1904

  Monteiro, Robson Q ^a   Bock, Paul E ^b   Bianconi, M Lucia ^a   Zingali, Russolina B ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

thrombin; Bothrojaracin; Exosite 1; Fluorescence polarization; Hirudin 54 65; Proexosite 1; Prothrombin; Titration calorimetry

Indexed keywords

ANION; BOTHROJARACIN; HIRUDIN; PROTHROMBIN; THROMBIN;

ARTICLE; BINDING AFFINITY; BINDING SITE; CALORIMETRY; COMPLEX FORMATION; DISSOCIATION CONSTANT; ENTHALPY; FLUORESCENCE POLARIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION;

ANIMALS; BINDING, COMPETITIVE; BOTHROPS; CALORIMETRY; CHROMATOGRAPHY, GEL; CROTALID VENOMS; FLUORESCENCE POLARIZATION; HUMANS; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTHROMBIN; THERMODYNAMICS; THROMBIN;

BOTHROPS JARARACA; SERPENTES;

EID: 0034841823     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.09001     Document Type: Article

References (44)

1. Characterization of proexosite 1 on prothrombin
2. Role of proexosite I in factor Va-dependent substrate interactions of prothrombin activation
3. Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin
4. Bothrojaracin, a potent two-site-directed thrombin inhibitor
5. Molecular cloning and expression of bothrojaracin, a potent thrombin inhibitor from snake venom
6. Inhibition of thrombin-catalyzed factor V activation by bothrojaracin
7. A novel blood coagulation factor IX/factor X-binding protein with anticoagulant activity from the venom of Trimeresurus flavoviridis (Habu snake): Isolation and characterization
8. The primary structure of coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis. Homology with asialoglycoprotein receptors, proteoglycan core protein, tetranectin, and lymphocyte Fe epsilon receptor for immunoglobulin E
9. Binding properties of the coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis
10. Interaction of human alpha-thrombin and gamma-thrombin with antithrombin III, protein C and thrombomodulin
11. Active-site-selective labeling of blood coagulation proteinases with fluorescence probes by the use of thioester peptide chloromethyl ketones. II. Properties of thrombin derivatives as reporters of prothrombin fragment 2 binding and specificity of the labeling approach for other proteinases
12. Inactivation of thrombin by antithrombin is accompanied by inactivation of regulatory exosite I
13. Modulation of human prothrombin activation on phospholipid vesicles and platelets using monoclonal antibodies to prothrombin fragment 2
14. Role of regulatory exosite I in binding of thrombin to human factor V. factor Va, factor Va subunits, and activation fragments
15. The association of bovine prothrombin fragment I with phospholipid
16. Human thrombins. Production, evaluation, and properties of alpha-thrombin
17. Evidence for allosteric linkage between exosites 1 and 2 of thrombin
18. Structure of the thrombin complex with triabin, a lipocalin-like exosite-binding inhibitor derived from a triatomine bug
19. A polypeptide region of bovine prothrombin specific for binding to phospholipids
20. Thrombin specificity
21. Allosteric changes in thrombin's activity produced by peptides corresponding to segments of natural inhibitors and substrates
22. Antithrombin activity of a peptide corresponding to residues 54-75 of heparin cofactor II
23. Electrostatic interactions in the association of proteins: An analysis of the thrombin-hirudin complex
24. The second kringle domain of prothrombin promotes factor Va-mediated prothrombin activation by prothronibinase
25. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex
26. Antithrombin properties of C-terminus of hirudin using synthetic unsulfated N-alpha-acetyl-hirudin45-65
27. The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity
28. Proteolytic formation of either of the two prothrombin activation intermediates results in formation of a hirugen-binding site
29. Prothrombin
30. Inhibition of prothrombin activation by bothrojaracin, a C-type lectin front Bothrops jararaca venom
31. Allosteric changes of thrombin catalytic site induced by interaction of bothrojaracin with anion-binding exosites I and II
32. The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alpha-thrombin on fibrinogen
33. A novel one-step purification of human α-thrombin after direct activation of crude prothrombin enriched from plasma
34. Thrombin exosite for fibrinogen recognition is partially accessible in prothrombin
35. Isolation and characterization of an anticoagulant protein homologous to botrocetin from the venom of Bothrops jararaca
36. Molecular mapping of the heparin-binding exosite of thrombin
37. A player of many parts: The spotlight falls on thrombin's structure
38. Isothermal titration calorimetry of biomolecules
39. The structures of domains of blood proteins
40. Crystallographic evidence that F2 kringle catalytic domain linker of prothrombin does not cover the fibrinogen recognition exosite
41. The effect of prothrombin fragment 2 on the inhibition of thrombin by antithrombin III
42. Activation-induced exposure of the thrombin anion-binding exosite
43. The fifth and sixth growth factor-like domains of thrombomodulin bind to the anion-binding exosite of thrombin and alter its specificity
44. Bothrojaracin, a new thrombin inhibitor isolated from Bothrops jararaca venom: Characterization and mechanism of thrombin inhibition